Filter

Filter by

  • Focus Area
      • More
      • More
      • More
      • More
      • More
      • More
  • Year

3688 Results

Newest

AIxBio Horizon Scan Finds Accelerating Capabilities Require Urgent Oversight

Risky Business

AIxBio Horizon Scan Finds Accelerating Capabilities Require Urgent Oversight

The convergence of artificial intelligence and the life sciences continues to accelerate. The AIxBio Horizon Scan: Spring 2026 shows that while individual advances may seem incremental, their combined trajectory is significant. Progress is outpacing governance frameworks.

The Legacy of Ted Turner: “We all have a stake.”

Risky Business

The Legacy of Ted Turner: “We all have a stake.”

Twenty-six years ago, Ted Turner watched a 60 Minutes II report that shook him. The segment highlighted a sobering reality: more than a decade after the end of the Cold War, thousands of nuclear weapons remained deployed around the world. Turner didn’t just take note—he acted.

AIxBio Horizon Scan: Spring 2026

Paper

AIxBio Horizon Scan: Spring 2026

Since the AIxBio Horizon Scan Winter 2025-2026 published in March 2026, there has been steady, incremental progress across AI-enabled biological tools. Protein design tools have continued to improve, agentic coding tools have matured in ways that lower barriers to computational biology, and commercial AI companies are making significant investments in the life sciences.

Load More

Close

My Resources

Subscribe to NTI

Sign up for regular updates on innovative, real-world solutions to existential threats.

Get Updates